Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Coumadin
Active Ingredient: Warfarin sodium 1mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Sigma Pharmaceuticals Australia Pty Limited, Dandenong, Australia
Hamol Limited, Nottingham, United Kingdom
Note: This renewed consent is valid for two years from 23 October 2010.
Product: Coumadin
Active Ingredient: Warfarin sodium 2mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Sigma Pharmaceuticals Australia Pty Limited, Dandenong, Australia
Hamol Limited, Nottingham, United Kingdom
Note: This renewed consent is valid for two years from 23 October 2010.
Product: Coumadin
Active Ingredient: Warfarin sodium 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Sigma Pharmaceuticals Australia Pty Limited, Dandenong, Australia
Hamol Limited, Nottingham, United Kingdom
Note: This renewed consent is valid for two years from 23 October 2010.
Dated this 5th day of August 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).